Unicycive Therapeutics (UNCY)
NASDAQ:UNCY
Want to see UNCY full AI Analyst Report?
UNCY Analyst Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
UNCY Stock 12 Month Forecast
Average Price Target
$45.86
▲(553.24% Upside)
| Highest Price Target$90.00 | Average Price Target$45.86 | Lowest Price Target$15.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
B. Riley Securities
$22
Buy
213.39%
Upside
Initiated
05/01/26
Benchmark Co.
$21→$15
Buy
113.68%
Upside
Reiterated
04/06/26
Guggenheim
$46→$40
Buy
469.80%
Upside
Reiterated
04/01/26
H.C. Wainwright
$22
Buy
213.39%
Upside
Reiterated
03/31/26
Noble Financial
$60
Buy
754.70%
Upside
Reiterated
03/31/26
Piper Sandler
$90
Buy
1182.05%
Upside
Reiterated
02/27/26
Maxim Group
$30
Buy
327.35%
Upside
Reiterated
12/29/25
Lucid Capital
$120
Buy
1609.40%
Upside
Initiated
06/04/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
B. Riley Securities
$22
Buy
213.39%
Upside
Initiated
05/01/26
Benchmark Co.
$21→$15
Buy
113.68%
Upside
Reiterated
04/06/26
Guggenheim
$46→$40
Buy
469.80%
Upside
Reiterated
04/01/26
H.C. Wainwright
$22
Buy
213.39%
Upside
Reiterated
03/31/26
Noble Financial
$60
Buy
754.70%
Upside
Reiterated
03/31/26
Piper Sandler
$90
Buy
1182.05%
Upside
Reiterated
02/27/26
Maxim Group
$30
Buy
327.35%
Upside
Reiterated
12/29/25
Lucid Capital
$120
Buy
1609.40%
Upside
Initiated
06/04/25
Best Analysts Covering Unicycive Therapeutics
3 Months
xxx
Success Rate
8/17 ratings generated profit
Average Return
+3.48%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 47.06% of your transactions generating a profit, with an average return of +3.48% per trade.
1 Year
Success Rate
10/11 ratings generated profit
Average Return
+25.76%
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +25.76% per trade.
2 Years
xxx
Success Rate
10/11 ratings generated profit
Average Return
+48.76%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +48.76% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
UNCY Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
8
7
8
7
6
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
7
8
7
6
Each month's total comprises the sum of three months' worth of ratings.
UNCY Financial Forecast
UNCY Stock Forecast FAQ
What is UNCY’s average 12-month price target, according to analysts?
Based on analyst ratings, Unicycive Therapeutics’s 12-month average price target is 45.86.
What is UNCY’s upside potential, based on the analysts’ average price target?
Unicycive Therapeutics has 553.24% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is UNCY a Buy, Sell or Hold?
Unicycive Therapeutics has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
What is Unicycive Therapeutics’s price target?
The average price target for Unicycive Therapeutics is 45.86. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $90.00 ,the lowest forecast is $15.00. The average price target represents 553.24% Increase from the current price of $7.02.
The highest analyst price target is $90.00 ,the lowest forecast is $15.00. The average price target represents 553.24% Increase from the current price of $7.02.
What do analysts say about Unicycive Therapeutics?
Unicycive Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of UNCY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.